"And while companies like 23andme and WellnessFX have a significant software component, the bigger story is that tech investors and entrepreneurs have moved beyond selling software to healthcare companies to starting healthcare companies."
Thorne's investment into WellnessFX recently won the Invest in the Future Award from NBJ. “The only way this type of medicine will be validated and accepted more globally is if we bring into the arenas where people are
big doubters.” —Will McCamy, Thorne Research (page 13)
WellnessFX affiliation with Thorne Research combines advanced diagnostic technology and resources to help medical professionals use personalized health information to improve patient outcomes.